Jeff D. Thostenson

Biostatistician II

University of Arkansas for Medical Sciences

faculty

16 h-index 45 pubs 1,708 cited

Research Areas

Bone health and treatments Substance Abuse Treatment and Outcomes Orthopedic Surgery and Rehabilitation Mitochondrial Function and Pathology Health Sciences Research and Education Metabolism and Genetic Disorders Endocrine System Diseases Research

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Jeff D. Thostenson's research focuses on biostatistics and its application in various biomedical fields. His work has contributed to studies investigating bone metabolism and resorption, including the role of osteoprotegerin and mitochondrial protein deacetylation in aging female mice. He has also been involved in research on lung and respiratory defects related to osteogenesis imperfecta and the utility of controlled amphetamine withdrawal paradigms in adults who use methamphetamine. Additionally, Thostenson has contributed to investigations into the reliability of clinical testing for laxity after knee arthroplasty and the development of predictive models for Graves’ disease recurrence. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Charles A. O’Brien, Joseph J. Goellner, Elena Ambrogini, and Michela Palmieri.

Metrics

h-index: 16
Publications: 45
Citations: 1,708

Selected Publications

Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone (2025) DOI
Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial (2025) DOI
Exploratory study of heart rate variability among participants with opioid use disorder inducted on gabapentin versus placebo during outpatient buprenorphine-assisted transition to injection naltrexone. (2025) DOI
Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice (2025) DOI
Sirtuin-3 promotes osteoclast maturation and bone loss by regulating mitochondrial ROS production during ionizing radiation exposure (2025) DOI
Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans (2025) DOI
A Predictive Model for Graves’ Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study (2024) DOI
A new <i>Col1a1</i> conditional knock-in mouse model to study osteogenesis imperfecta (2024) DOI
Frequency and Determinants of Levothyroxine Therapy Initiation for Veterans with Subclinical Hypothyroidism (2024) DOI
Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation (2023) DOI
CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system (2023) DOI
Distinct type I collagen alterations cause intrinsic lung and respiratory defects of variable severity in mouse models of osteogenesis imperfecta (2022) DOI
Inter-Rater Reliability of Clinical Testing for Laxity After Knee Arthroplasty (2022) DOI
Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial (2021) DOI
Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo (2021) DOI